U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07827456) titled 'MRI-Guided Temporal Interference Stimulation for Parkinson's Disease' on Sept. 14.
Brief Summary: This study aims to evaluate the efficacy and safety of tTIS treatment in patients with Parkinson's disease (PD). The study will enroll eligible PD patients and randomly assign them to two groups: Group A will first receive combined GPi and STN stimulation, followed by GPi stimulation one week later; Group B will first receive GPi stimulation, followed by combined GPi and STN stimulation one week later. The MDS-UPDRS Part III will be assessed at pre-stimulation baseline, immediately after stimulation, and at 30 and 60 minutes post-stimu...